2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

The Putamen to Caudate Nucleus Ratio: A Simple Surrogate Marker for Dopaminergic Volume in Putamen

J.J. Lee, Y.H. Sohn (Goyang-si, Republic of Korea)
The Relationship between Olfactory Function and Clinical Subtypes of Parkinson’s Disease

D.-Y. Kwon (Ansan, Republic of Korea)
The Relative Preservation of the Dopaminergic Neuroal Loss of Patients with Parkinson’s Disease Having Dopamine-Unresponsive Resting Tremor

S. You, H.W. Kim (Daegu, Republic of Korea)
The Role of Clinical Outcome Assessment (COA) Data in the Drug Approval Process of Medicines for the Treatment of Restless Legs Syndrome (RLS): A Review of the Labels of Medicines Approved by the FDA and the EMA

M.-P. Emery, C. Anfray, L.-L. Perrier, C. Acquadro (Lyon, France)
The role of habenula and amygdala dysfunction in Parkinson’s disease patients with punding

V. Markovic, F. Agosta, E. Canu, A. Inuggi, I. Petrovic, I. Stankovic, F. Imperiale, T. Stojkovic, V. Kostic, M. Filippi (Belgrade, Serbia)
The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report

A. Tran, M. Amin, R. Burns (Phoenix, AZ, USA)
The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease

H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, M. Mehta, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)
The Role of Social Work in Improving Comprehensive Care for Parkinson’s Disease

E. Book, A. Lemen (Vancouver, BC, Canada)
The Roles of Diet, Exercise, & Supplements in Parkinson’s Disease Progression

L. Mischley, R. Lau (Kenmore, WA, USA)
The secular change of quality of life in patients with Parkinson’s disease.

A. Kumon, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z